Related Experiment Video
Updated: Apr 7, 2026
06:32
Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
Published on: September 1, 2010
16.9K
Sexual dimorphism in medulloblastoma features
Gian Franco Zannoni1, Alessandra Ciucci2, Gianluca Marucci3
1Department of Histopathology, Catholic University of the Sacred Heart, Rome, Italy.
Histopathology
|July 2, 2015
Summary
Male sex is a risk factor for medulloblastoma (MB). This study found sex-specific tumor features, with female tumors showing higher apoptosis and less vascularization, suggesting hormonal influences on MB biology.
Area of Science:
- Oncology
- Neuroscience
- Endocrinology
Background:
- Male sex is a known risk factor and negative predictor for medulloblastoma (MB) patient outcomes.
- Understanding sex-based differences in MB tumor biology is crucial for improving treatment strategies.
Purpose of the Study:
- To investigate sex differences in medulloblastoma tumor biological features.
- To analyze hormone receptor profiles in relation to patient sex.
Main Methods:
- Immunohistochemistry was used to evaluate cell proliferation (Ki67), apoptosis (cleaved caspase-3), and microvessel density (CD31) in 64 MB tumors.
- Analysis included assessment of estrogen receptor (ER) and androgen receptor (AR) expression.
Main Results:
- Female MB tumors exhibited a higher apoptosis/proliferation ratio and reduced vascularization compared to male tumors.
- All MBs were negative for ERα and AR but expressed ERβ isoforms similarly across sexes.
- Signaling pathways regulating cell turnover and angiogenesis appear more efficient in females.
Conclusions:
- Findings provide molecular evidence supporting epidemiological data on sex differences in MB incidence and outcomes.
- The study fully characterizes the hormone receptor profile of medulloblastoma.
- Circulating estrogens may be key determinants of observed sexual dimorphism in MB features.
